ATRS

Antares Pharma, Inc.

Delisted

ATRS was delisted on the 23rd of May, 2022.

174 hedge funds and large institutions have $291M invested in Antares Pharma, Inc. in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 53 reducing their positions, and 13 closing their positions.

Holders
174
Holders Change
+10
Holders Change %
+6.1%
% of All Funds
3.09%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
23
Increased
50
Reduced
53
Closed
13
Calls
$595K
Puts
$1.45M
Net Calls
-$853K
Net Calls Change
-$333K
Name Holding Trade Value Shares
Change
Shares
Change %
ACM
176
Asymmetry Capital Management
California
-$3.23M -1,194,530 Closed
MFAM
177
Motley Fool Asset Management
Virginia
-$2.49M -877,667 Closed
AC
178
Armistice Capital
New York
-$1.16M -428,000 Closed
Renaissance Technologies
179
Renaissance Technologies
New York
-$916K -339,213 Closed
MWNA
180
Marshall Wace North America
New York
-$396K -147,025 Closed
HF
181
HRT Financial
New York
-$320K -118,784 Closed
EP
182
Eudaimonia Partners
Tennessee
-$54K -20,000 Closed
SS
183
Simplicity Solutions
Minnesota
-$49K -18,266 Closed
E
184
Ergoteles
New York
-$47K -17,400 Closed
AIM
185
Alambic Investment Management
California
-$45K -16,769 Closed
AAS
186
Avantax Advisory Services
Texas
-$42K -15,500 Closed
CHAM
187
Clear Harbor Asset Management
Connecticut
-$8.1K -3,000 Closed